Pediatric ADHD Excellence Forum

Pediatric ADHD

Excellence Forum

Leaders in the field sharing authoritative insights and institutional best practices.

Videos

Can Lifestyle Interventions Reduce the Risk of Children Developing ADHD?

11/12/2020

In this video, Vladimir Maletic, MD, MS, discusses whether lifestyle interventions can help reduce the risk of children developing attention deficit/hyperactivity disorder (ADHD).

In this video, Vladimir Maletic,...

11/12/2020

Psych Congress Network

Videos

Improving Outcomes in ADHD Through Early Treatment

09/23/2020

Psych Congress 2020 presenter c, discusses the ways in which early treatment can improve outcomes in patients with attention-deficit/hyperactivity disorder (ADHD).

Psych Congress 2020 presenter c,...

09/23/2020

Psych Congress Network

Videos

Treating Comorbidities in Patients With ADHD

09/22/2020

Psych Congress 2020 cochair Vladimir Maletic, MD, MS, discusses the risks associated with comorbid conditions in patients with attention deficit/hyperactivity disorder (ADHD) and strategies for treating them.

Psych Congress 2020 cochair...

09/22/2020

Psych Congress Network

Videos

Should You Start ADHD Treatment With a Stimulant or Nonstimulant?

08/26/2019

When a patient is newly diagnosed with attention-deficit/hyperactivity disorder (ADHD), is it better to begin treatment with a stimulant or a nonstimulant? Anthony L. Rostain, MD, MA, shares his thoughts in this video.

When a patient is newly...

08/26/2019

Psych Congress Network

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

Rapid Refresh

Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics

04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...

Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...

Andrew Penn, MS, PMHNP, and...

04/11/2024

Psych Congress NP Institute

Rapid Refresh

Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder

04/10/2024

Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...

Amber Hoberg, PMHNP-BC,...

04/10/2024

Psych Congress NP Institute

Clinical Pearls

Tolerability Testing in Long-Acting Injectable Prescriptions

04/03/2024

Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.

Pediatric ADHD Excellence Forum

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

Sign Up

Specialties

Events

Year Round Education

HMP Global Products